Connor, Clark & Lunn Investment Management (CC&L)’s Idexx Laboratories IDXX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-969
Closed -$520K 1604
2025
Q2
$520K Buy
+969
New +$463K ﹤0.01% 1246
2024
Q2
Sell
-663
Closed -$358K 1517
2024
Q1
$358K Buy
+663
New +$362K ﹤0.01% 1208
2022
Q4
Sell
-3,716
Closed -$1.21M 1314
2022
Q3
$1.21M Sell
3,716
-7,013
-65% -$2.58M 0.01% 607
2022
Q2
$3.76M Buy
10,729
+7,311
+214% +$2.98M 0.02% 362
2022
Q1
$1.87M Buy
3,418
+1,252
+58% +$659K 0.01% 515
2021
Q4
$1.43M Sell
2,166
-1,638
-43% -$1.03M 0.01% 608
2021
Q3
$2.37M Sell
3,804
-23,015
-86% -$15.5M 0.01% 491
2021
Q2
$16.9M Sell
26,819
-6,781
-20% -$3.74M 0.09% 184
2021
Q1
$16.4M Buy
33,600
+12,960
+63% +$6.49M 0.09% 173
2020
Q4
$10.3M Sell
20,640
-210
-1% -$94K 0.06% 223
2020
Q3
$8.2M Buy
20,850
+8,025
+63% +$2.97M 0.05% 228
2020
Q2
$4.23M Buy
12,825
+11,220
+699% +$3.25M 0.03% 326
2020
Q1
$389K Sell
1,605
-2,845
-64% -$742K ﹤0.01% 752
2019
Q4
$1.16M Buy
4,450
+1,550
+53% +$408K 0.01% 521
2019
Q3
$789K Buy
2,900
+1,650
+132% +$459K 0.01% 590
2019
Q2
$344K Buy
+1,250
New +$308K ﹤0.01% 797
2018
Q4
Sell
-2,050
Closed -$512K 990
2018
Q3
$512K Sell
2,050
-8,300
-80% -$2.01M ﹤0.01% 695
2018
Q2
$2.26M Sell
10,350
-1,400
-12% -$288K 0.01% 449
2018
Q1
$2.25M Sell
11,750
-100
-0.8% -$18.5K 0.01% 375
2017
Q4
$1.85M Buy
11,850
+5,600
+90% +$881K 0.01% 428
2017
Q3
$972K Buy
6,250
+3,850
+160% +$609K 0.01% 535
2017
Q2
$387K Buy
+2,400
New +$390K ﹤0.01% 644

Other funds holding IDXX